We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$10.7B
AUM Growth
+$199M
Cap. Flow
-$591M
Cap. Flow %
-5.53%
Top 10 Hldgs %
13.09%
Holding
255
New
28
Increased
68
Reduced
132
Closed
22

Top Buys

Rank Stock Value
1
FROG icon
JFrog
FROG
+$56.3M
2
CSL icon
Carlisle Companies
CSL
+$54.5M
3
KMX icon
CarMax
KMX
+$50.4M
4
JKHY icon
Jack Henry & Associates
JKHY
+$45.2M
5
BAND
Bandwidth Inc
BAND
+$40.6M

Sector Composition

Rank Sector Weight
1 Technology 32.85%
2 Healthcare 19.97%
3 Industrials 14.83%
4 Consumer Discretionary 10.25%
5 Financials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
251
DELISTED
Global Blood Therapeutics, Inc.
GBT
-1,263,710
Closed -$79.8M
WORK
252
DELISTED
Slack Technologies, Inc.
WORK
-40,084
Closed -$1.25M
RST
253
DELISTED
ROSETTA STONE INC
RST
-1,188,460
Closed -$20M
SIVB
254
DELISTED
SVB Financial Group
SIVB
-138,900
Closed -$29.9M

Similar funds

TimesSquare Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, TimesSquare Capital Management held 255 positions worth $10.7B, up 1.9% from $10.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $591M in Q3 2020, closing 22 positions and reducing 132 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $79.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in JFrog worth $64M.

  • TimesSquare Capital Management's largest Q3 2020 buy was JFrog: 755,640 shares worth $64M.
  • TimesSquare Capital Management added most to Jack Henry & Associates in Q3 2020, an estimated $45.2M increase.
  • TimesSquare Capital Management's biggest Q3 2020 reduction was iRhythm Holdings, cutting an estimated $62.4M.
  • TimesSquare Capital Management fully exited Global Blood Therapeutics, Inc. in Q3 2020, selling an estimated $79.8M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.7B portfolio in Q3 2020.
  • TimesSquare Capital Management opened 28 new positions and closed 22 in Q3 2020.
  • TimesSquare Capital Management's portfolio value rose 1.9% quarter-over-quarter to $10.7B.

Based on TimesSquare Capital Management's 13F filing for Q3 2020, filed 6 Nov 2020.